Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥503.00 JPY
Change Today -4.00 / -0.79%
Volume 13.0K
4557 On Other Exchanges
As of 12:13 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

medical & biological labs co (4557) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/1/15 - ¥655.00
52 Week Low
01/27/15 - ¥414.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICAL & BIOLOGICAL LABS CO (4557)

Related News

No related news articles were found.

medical & biological labs co (4557) Related Businessweek News

No Related Businessweek News Found

medical & biological labs co (4557) Details

Medical & Biological Laboratories Co., Ltd. researches, develops, manufactures, and sells a range of in vitro diagnostics (IVDs) and research reagents worldwide. It offers IVDs for autoimmune diseases, cancers, genetic diseases, infectious diseases, and allergies; gene mutation detection kit, and human leukocyte antigen and human platelet antigen DNA typing reagents; and tumor markers for multiple myeloma and urothelial carcinoma, as well as measures tumor-related autoantibodies. The company also offers TACAS, a liquid-based cytology system, which enables standardization of reagents and instruments used in cytological examination; MEBGEN, a human papilloma virus (HPV) kit that enables detection of HPV genotypes, as well as provides information for diagnosis and treatment of cervical cancer; GENOSEARCH HPV 31, which detects 31 types of the HPV genes; and Cervex-Brush and Cervex-Brush COMBI, which collects and smears cells in a single smear collection from cells in the neck of the womb. In addition, it develops, manufactures, and markets antibodies and reagents necessary for research in molecular and cell biology; and provides total solution services that resolve problems in epitope tags, autophagy, epigenetics, MHC tetramer, iPS, fluorescent proteins, immunology, metabolism, drug screening, and custom services fields. Further, the company sponsors symposium; hosts seminars; exhibits in medical and scientific meetings to introduce products and technologies through tradeshows; publishes newsletter, autoimmunity report, and autoantibodies and autoimmunity publications; and conducts quality control survey of the autoantibodies. It offers in vitro diagnostics to hospitals and clinical testing centers; and research reagents to pharmaceutical and biological companies, research facilities, and universities. Medical & Biological Laboratories Co., Ltd. was founded in 1969 and is headquartered in Nagoya, Japan.

440 Employees
Last Reported Date: 06/24/15
Founded in 1969

medical & biological labs co (4557) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medical & biological labs co (4557) Key Developments

Medical & Biological Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2015

Medical & Biological Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2015.

Medical & Biological Laboratories, Co., Ltd. Opens MBL Europe Office in Diegem (Mechelen), Belgium

Medical & Biological Laboratories Co., Ltd. has announced the opening of MBL Europe office in Diegem (Mechelen), Belgium as a new liaison/representative office. MBL Europe represents the third global hub outside of Japan and will strengthen the business segment for personalised medicine and cell therapy fields in Europe. More specifically, MBL Europe will be responsible for customer support for ''MEBGEN RASKET KIT' which can detect both KRAS and NRAS gene mutations and is useful for therapeutic decision prior to anti-EGFR monoclonal antibody therapy to colon cancer. The office will also provide support throughout Europe for MHC Tetramer product line which can detect antigen-specific T cells directly and quantitatively in immune therapy in fields such as cancer vaccines. MBL Europe, as strategic hub of MBL Group, will build closer relationship with the European distributors in life science business, and explore new business opportunities in high growth areas including molecular diagnostics, personalised medicine and cell therapy fields.

Medical & Biological Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2014

Medical & Biological Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4557:JP ¥503.00 JPY -4.00

4557 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4557.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4557 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDICAL & BIOLOGICAL LABS CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at